DVAX logo

Dynavax Technologies (DVAX)

Profile

Full Name

Dynavax Technologies Corporation

Ticker Symbol

DVAX

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

February 19, 2004

Indexes

Not included

Website

http://www.dynavax.com

Employees

405

Key Details

Price

$10.65(-6.66%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$277.25M(+19.36% YoY)

Annual EPS

$0.20(+500.00% YoY)

PE ratio

59.17

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$10.65
DVAX price is $10.65

30-Day Relative Volume

0.86
DVAX 30-day relative volume is 0.86

Price Performance

Price Today change

-6.66%
DVAX price is down -6.66% today

Price YTD change

-16.6%
DVAX price is down -16.6% since January 1st

Price 1-year change

-7.31%
DVAX price is down -7.31% year-on-year

Price 3-year change

+1.33%
DVAX price is up +1.33% over the past 3 years

Price Range

Price All-time high

$106.60
DVAX price is currently -90.01% below its historical high of $106.60

Price 3-year low

$7.26
DVAX price is currently +46.69% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.32B
DVAX market capitalization is $1.32 billion

Market cap 3-year change

-0.47%
DVAX market capitalization is down -0.47% over the past 3 years

Market cap All-time high

$2.51B
DVAX market capitalization is currently -47.39% below its historical high of $2.51 billion

Market cap sector rank

79.28%
DVAX market capitalization is higher than 79.28% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-5.19%
DVAX shares outstanding is down -5.19% year-on-year

Shares Outstanding 3-Year Change

-1.77%
DVAX shares outstanding is down -1.77% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.46
DVAX beta is 0.46

200-day SMA

$12.08
DVAX price is currently -11.86% below its 200-day simple moving average

50-day SMA

$13.14
DVAX price is currently -18.94% below its 50-day simple moving average

RSI

26.29
DVAX 14-day relative strength index is 26.29

Volume

0.86
DVAX 30-day relative volume is 0.86

ATR

$0.53
DVAX average true range is $0.53

10-day Historical Volatility

63.44%
DVAX 10-day historical volatility is 63.44%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$277.25M
DVAX annual revenue is $277.25 million

Revenue Analysts estimate

$326.35M
DVAX annual revenue is currently -15.05% lower than the consensus analysts' forecast

Revenue 1-year change

+19.36%
DVAX annual revenue is up +19.36% year-on-year

Revenue Sector rank

67.71%
DVAX annual revenue is higher than 67.71% of companies in Healthcare sector

EPS

EPS

$0.20
DVAX annual earnings per share is $0.20

EPS Analysts estimate

$0.32
DVAX annual earnings per share is currently -37.50% lower than the consensus analysts' forecast

EPS 1-year change

+500%
DVAX annual earnings per share is up +500% year-on-year

EPS Sector rank

85.09%
DVAX annual earnings per share is higher than 85.09% of companies in Healthcare sector

Profit

Gross profit

$227.80M
DVAX annual gross profit is $227.80 million

Gross margin

82.17%
DVAX annual gross profit margin is 82.17%

Operating profit

-$4.12M
DVAX annual operating income is -$4.12 million

Operating margin

-1.49%
DVAX annual operating profit margin is -1.49%

Net income

$27.31M
DVAX annual net profit is $27.31 million

Net margin

9.85%
DVAX annual net profit margin is 9.85%

Expenses

Total expenses

$281.37M
DVAX annual total expenses is $281.37 million

Operating expenses

$231.92M
DVAX annual total operating expenses is $231.92 million

Cost of goods sold

$49.45M
DVAX annual cost of goods sold is $49.45 million

Selling, general & administrative expenses

$170.37M
DVAX annual SGA is $170.37 million

Depreciation and amortization

$8.05M
DVAX annual depreciation & amortization is $8.05 million

Interest expense

$6.79M
DVAX annual interest expense is $6.79 million

Income tax

$3.55M
DVAX annual income tax is $3.55 million

EBIT & EBITDA

EBIT

$37.65M
DVAX annual earnings before interest & taxes is $37.65 million

EBITDA

$45.70M
DVAX annual EBITDA is $45.70 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$986.26M
DVAX annual total assets is $986.26 million

Non current assets

$137.31M
DVAX annual long term assets is $137.31 million

Current assets

$848.94M
DVAX annual total current assets is $848.94 million

Cash and cash equivalents

$95.88M
DVAX annual cash & cash equivalents is $95.88 million

Accounts receivable

$45.28M
DVAX annual accounts receivable is $45.28 million

Inventory

$70.05M
DVAX annual inventory is $70.05 million

Liabilities

Total liabilities

$389.46M
DVAX annual total liabilities is $389.46 million

Long term liabilities

$310.82M
DVAX annual total long term liabilities is $310.82 million

Current liabilities

$78.63M
DVAX annual total current liabilities is $78.63 million

Accounts payable

$9.06M
DVAX annual accounts payable is $9.06 million

Debt

Total debt

$254.42M
DVAX annual total debt is $254.42 million

Total debt 1-year change

-0.97%
DVAX annual total debt is down -0.97% year-on-year

Long term debt

$250.24M
DVAX annual long term debt is $250.24 million

Short term debt

$4.17M
DVAX annual short term debt is $4.17 million

Equity & Capital

Shareholders equity

$596.80M
DVAX annual stockholders equity is $596.80 million

Book value

$596.80M
DVAX annual book value is $596.80 million

Retained earnings

-$903.27M
DVAX annual retained earnings is -$903.27 million

Working capital

$770.31M
DVAX annual working capital is $770.31 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$66.51M
DVAX annual cash flow from operations is $66.51 million

Cash from operations 1-year change

-33.86%
DVAX annual cash flow from operations is down -33.86% year-on-year

Cash from investing

-$18.04M
DVAX annual cash flow from investing activities is -$18.04 million

Cash from investing 1-year change

+88.28%
DVAX annual cash flow from investing activities is up +88.28% year-on-year

Cash from financing

-$102.02M
DVAX annual cash flow from financing activities is -$102.02 million

Cash from financing 1-year change

-7460.53%
DVAX annual cash flow from financing activities is down -7460.53% year-on-year

CAPEX

CAPEX

$6.35M
DVAX annual capital expenditures is $6.35 million

CAPEX 1-year change

+54.78%
DVAX annual capital expenditures is up +54.78% year-on-year

Free Cash Flow

Free cash flow

$60.16M
DVAX annual free cash flow is $60.16 million

Free cash flow 1-year change

-37.63%
DVAX annual free cash flow is down -37.63% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

82.17%
DVAX annual gross profit margin is 82.17%

Operating margin

-1.49%
DVAX annual operating profit margin is -1.49%

Net margin

9.85%
DVAX annual net profit margin is 9.85%

ROA & ROE

ROA

2.75%
DVAX annual return on assets is 2.75%

ROE

4.48%
DVAX annual return on equity is 4.48%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

59.17
DVAX price to earnings ratio is 59.17

PE ratio Sector rank

83.33%
DVAX price to earnings ratio is higher than 83.33% of companies in Healthcare sector

PB Ratio

PB ratio

2.21
DVAX price to book ratio is 2.21

PB ratio Sector rank

65.93%
DVAX price to book ratio is higher than 65.93% of companies in Healthcare sector

PS Ratio

PS ratio

4.77
DVAX price to sales ratio is 4.77

PS ratio Sector rank

65.26%
DVAX price to sales ratio is higher than 65.26% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.48B
DVAX enterprise value is $1.48 billion

Enterprise value Sector rank

78.91%
DVAX enterprise value is higher than 78.91% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

32.38
DVAX EV/EBITDA is 32.38

EV/EBITDA Sector rank

95.39%
DVAX EV/EBITDA is higher than 95.39% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

10.80
DVAX annual current ratio is 10.80

Quick ratio

9.91
DVAX annual quick ratio is 9.91

Leverage

Debt to equity

0.38
DVAX annual debt to equity ratio is 0.38

Interest coverage ratio

5.54
DVAX annual interest coverage ratio is 5.54

Risk & Stability

Piotroski F-Score

6
DVAX piotroski f-score is 6

Altman Z-Score

2.10
DVAX altman z-score is 2.10

Analyst ratings

Recent major analysts updates

Feb 21, 25 HC Wainwright & Co.
Buy
Feb 21, 25 Citizens Capital Markets
Market Outperform
Feb 11, 25 Goldman Sachs
Sell
Jan 14, 25 HC Wainwright & Co.
Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 15, 24 HC Wainwright & Co.
Buy
Aug 8, 24 Goldman Sachs
Neutral
Aug 7, 24 HC Wainwright & Co.
Buy
Jun 28, 24 HC Wainwright & Co.
Buy
May 14, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

MNKD logo
MannKind (MNKD)
PHR logo
Phreesia (PHR)
PACS logo
PACS (PACS)
Disc Medicine (IRON)
ATEC logo
Alphatec Holdings (ATEC)
NHC logo
National HealthCare (NHC)
BEAM logo
Beam Therapeutics (BEAM)
VERA logo
Vera Therapeutics (VERA)
MESO logo
Mesoblast Limited (MESO)
  • What is the ticker symbol for Dynavax Technologies?
  • Does Dynavax Technologies pay dividends?
  • What sector is Dynavax Technologies in?
  • What industry is Dynavax Technologies in?
  • What country is Dynavax Technologies based in?
  • When did Dynavax Technologies go public?
  • Is Dynavax Technologies in the S&P 500?
  • Is Dynavax Technologies in the NASDAQ 100?
  • Is Dynavax Technologies in the Dow Jones?
  • When was Dynavax Technologies's last earnings report?
  • When does Dynavax Technologies report earnings?
  • Should I buy Dynavax Technologies stock now?

What is the ticker symbol for Dynavax Technologies?

The ticker symbol for Dynavax Technologies is NASDAQ:DVAX

Does Dynavax Technologies pay dividends?

No, Dynavax Technologies does not pay dividends

What sector is Dynavax Technologies in?

Dynavax Technologies is in the Healthcare sector

What industry is Dynavax Technologies in?

Dynavax Technologies is in the Drug Manufacturers - Specialty & Generic industry

What country is Dynavax Technologies based in?

Dynavax Technologies is headquartered in United States

When did Dynavax Technologies go public?

Dynavax Technologies's initial public offering (IPO) was on February 19, 2004

Is Dynavax Technologies in the S&P 500?

No, Dynavax Technologies is not included in the S&P 500 index

Is Dynavax Technologies in the NASDAQ 100?

No, Dynavax Technologies is not included in the NASDAQ 100 index

Is Dynavax Technologies in the Dow Jones?

No, Dynavax Technologies is not included in the Dow Jones index

When was Dynavax Technologies's last earnings report?

Dynavax Technologies's most recent earnings report was on Feb 20, 2025

When does Dynavax Technologies report earnings?

The next expected earnings date for Dynavax Technologies is May 8, 2025

Should I buy Dynavax Technologies stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page